Search Results - "Ajana, F"

The yield of EUS guided sampling in biliopancreatic masses by Azzouzi, Driss, Borahma, M., f. Chabib, Benelbarhdadi, I., Ajana, F.

Get full text

RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients by Alidjinou, E K, Deldalle, J, Hallaert, C, Robineau, O, Ajana, F, Choisy, P, Hober, D, Bocket, L

“…Sanger sequencing of plasma RNA is the standard method for HIV-1 drug resistance testing in treatment-naive patients, but is limited by the non-detection of…”
Get full text

Endoscopic treatment of ruptured hepatic hydatid cyst into the biliary tree by El mamouni, Sakina, Borahma, M., Chabib, F., Benelbarhdadi, I., Ajana, F.

Get full text

The yield of EUS guided sampling in Cystic pancreatic neoplasms by HONSALI, Youssef AL, BORAHMA, M., CHABIB, F., BENELBARHDADI, I., AJANA, F.

Get full text

Difficulty in reaching viral suppression in a long-term treated HIV-1 patient: Role of the reservoir rather than drug resistance? by Alidjinou, E.K., Robineau, O., Huleux, T., Meybeck, A., Hober, D., Ajana, F., Bocket, L.

Get full text

Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study by Valantin, M. A., Lambert-Niclot, S., Flandre, P., Morand-Joubert, L., Cabiè, A., Meynard, J. L., Ponscarme, D., Ajana, F., Slama, L., Curjol, A., Cuzin, L., Schneider, L., Taburet, A. M., Marcelin, A. G., Katlama, C.

“…Objectives Long-term results at week 96 are needed to evaluate the capacity of the darunavir/ritonavir monotherapy strategy to maintain a sustained control of…”
Get full text

Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients by Bocket, L, Peytavin, G, Alidjinou, E K, Ajana, F, Choisy, P, Lê, M, Charpentier, C, Descamps, D, Yazdanpanah, Yazdan, Katlama, C, Simon, A, Calvez, V, Marcelin, A-G, Soulie, C

“…There are few data on clinical and virological factors associated with maraviroc virological response (VR) in clinical practice. This study aimed to identify…”
Get full text

The history of plasma viral load and CD4 count impacts the size of HIV-1 reservoir by Alidjinou, E.K, Robineau, O, Chéret, A, Ajana, F, Drumez, E, Kyheng, M, Choisy, P, Hober, D, Bocket, L

Get full text

Osteomyelitis of the wrist caused by Mycobacterium arupense in an immunocompetent patient: a unique case by Legout, L, Ettahar, N, Massongo, M, Veziris, N, Ajana, F, Beltrand, E, Senneville, E

Get full text

Switching to DTG/3TC fixed-dose combination (FDC) Is non-inferior to continuing a TAF-based regimen in maintaining virologic suppression through 48 weeks (TANGO Study) by Van Wyk, J., Ajana, F., Bisshop, F., De Wit, S., Osiyemi, Y., Portilla, J., Routy, J., Wyen, C., Ait-Khaled, M., Nascimento, M., Pappa, K., Wang, R., Wright, J., Tenorio, A., Wynne, B., Aboud, M., Gartland, M., Smith, K., El-Bahy, Y.

Get full text

Hepatitis B virus still under debate by Ajana, F

“…Hepatitis B is the most known viral hepatitis, and often turns into a media event in France. Its prevalence and incidence depend on countries, regions, and…”
Get full text

Cryptococcal osteomyelitis in a patient with a lymphocytic leukemia treated with fludarabine-cyclophosphamide-rituximab by Ettahar, N, Legout, L, Ajana, F, Patoz, P, Massongo, M, Rose, C, Senneville, E

“…Cryptococcosis is a serious invasive fungal infection mostly described in patients with cell-mediated immunosuppression. Cryptococcus neoformans osteomyelitis…”
Get full text

Commercial watercress as an emerging source of fascioliasis in Northern France in 2002: results from an outbreak investigation by MAILLES, A., CAPEK, I., AJANA, F., SCHEPENS, C., ILEF, D., VAILLANT, V.

“…In April 2002, five cases of fascioliasis were diagnosed in Tourcoing. A case-finding and a case-control study were carried out to identify the source of the…”
Get full text

Catch-up vaccination of worldwide newcoming (adopted, refugee or migrant) children in France by de Monléon, J-V, Regnier, F, Ajana, F, Baptiste, C, Callamand, P, Cheymol, J, Gillet, Y, Hau-Rainsard, I, Lorrot, M, Reinert, P, Marchand, S, Okaïs, C, Picherot, G

“…In France, international adoption includes around to 90,000 children since 1980 and near 300,000 immigrant children were counted in 2008. This population is…”
Get full text

Vaccination in adults with auto-immune disease and/or drug related immune deficiency: Results of the GEVACCIM Delphi survey by Duchet-Niedziolka, P, Launay, O, Coutsinos, Z, Ajana, F, Arlet, P, Barrou, B, Beytout, J, Bouchaud, O, Brouqui, P, Buzyn, A, Chidiac, C, Couderc, L.J, Debord, T, Dellamonica, P, Dhote, R, Duboust, A, Durrbach, A, Fain, O, Fior, R, Godeau, B, Goujard, C, Hachulla, E, Marchou, B, Mariette, X, May, T, Meyer, O, Milpied, N, Morlat, P, Pouchot, J, Tattevin, P, Viard, J.P, Lortholary, O, Hanslik, T

“…Abstract Introduction There are insufficient data regarding the efficacy and safety of vaccination in patients with auto-immune disease (AID) and/or…”
Get full text

Mesalamine enema-induced exacerbation of ulcerative colitis by Bousseaden, A., Ajana, F. Z., Essamri, W., Benelbarhdadi, I., Afifi, R., Benazzouz, M., Essaid, A.

Get full text

Impact of human immunodeficiency virus type 1 subtype on first-line antiretroviral therapy effectiveness by BOCKET, Laurence, CHERET, Antoine, MOUTON, Yves, YAZDANPANAH, Yazdan, DEUFFIC-BURBAN, Sylvie, CHOISY, Philippe, GERARD, Yann, DE LA TRIBONNIERE, Xavier, VIGET, Nathalie, AJANA, Faïzo, GOFFARD, Anne, BARIN, Francis

“…The effectiveness of antiretroviral treatment (ART) was compared in 416 naive patients from a French clinical cohort infected with B and non-B HIV-1 subtypes…”
Get full text

Development of a PCR Assay Followed by Nonradioactive Hybridization Using Oligonucleotides Covalently Bound to CovaLink NH Microwells for Detection of Four Plasmodium Species in Blood Samples from Humans by Machouart, M, Bigois-Delemotte, L, Ajana, F, Brizion, M, Biava, M.F, Collomb, J, Fortier, B

“…We developed and evaluated a PCR-based assay to detect four Plasmodium species in 79 blood samples from 56 travelers returning from areas where malaria is…”
Get full text

Incidence rate and risk factors for loss to follow‐up in a French clinical cohort of HIV‐infected patients from January 1985 to January 1998 by Lebouché, B, Yazdanpanah, Y, Gérard, Y, Sissoko, D, Ajana, F, Alcaraz, I, Boitte, P, Cadoré, B, Mouton, Y

“…Objectives To determine the incidence rate and risk factors for loss to follow‐up (LFU) in HIV‐infected individuals. Methods We estimated the incidence rate of…”
Get full text

L'hépatite virale B, encore et toujours d'actualité by Ajana, F.

“…L'hépatite virale B (HVB) est la plus connue et la plus médiatisée des hépatites, notamment en France. Sa prévalence et son incidence sont variables selon les…”
Get full text